Salmonella Bloodstream Infection Secondary to Treatment with Baricitinib in COVID-19

被引：0
|
作者：
Amos, Shoshana [1 ,4 ,5 ]
Elinav, Hila [2 ,3 ]
Parnasa, Elchanan [1 ]
机构：
[1] Hebrew Univ Jerusalem, Fac Med, Hadassah Med Org, Dept Internal Med, Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Org, Fac Med, Dept Clin Microbiol & Infect Dis, Jerusalem, Israel
[3] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel
[4] Hebrew Univ Jerusalem, Hadassah Med Org, Dept Internal Med, IL-91120 Jerusalem, Israel
[5] Hebrew Univ Jerusalem, Fac Med, IL-91120 Jerusalem, Israel
来源：
ISRAEL MEDICAL ASSOCIATION JOURNAL | 2023年 / 25卷 / 01期
关键词：
bacteremia; baricitinib; coronavirus disease 2019 (COVID-19); Salmonella enterica; thromboembolism;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：78 / 78
页数：1
相关论文
共 50 条
  • [1] Secondary bloodstream infection in critically ill patients with COVID-19
    Zhang, Junli
    Lan, Peng
    Yi, Jun
    Yang, Changming
    Gong, Xiaoyan
    Ge, Huiqing
    Xu, Xiaoling
    Liu, Limin
    Zhou, Jiancang
    Lv, Fangfang
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (12)
  • [2] Baricitinib for COVID-19: a suitable treatment?
    Favalli, Ennio G.
    Biggioggero, Martina
    Maioli, Gabriella
    Caporali, Roberto
    [J]. LANCET INFECTIOUS DISEASES, 2020, 20 (09): : 1012 - 1013
  • [3] The Impact of Secondary Catheter-Related Bloodstream Infection on the Course of COVID-19 Infection
    Nadir, Yasemin
    Kiran, Pinar
    Erturk, Damla
    Uzun, Ugur
    Yavuz, Tunzala
    Ersan, Gursel
    Ozden, Hale Turan
    Senger, Suheyla Serin
    [J]. INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2024, 22 (02)
  • [4] Baricitinib for COVID-19: a suitable treatment? Reply
    Richardson, Peter J.
    Corbellino, Mario
    Stebbing, Justin
    [J]. LANCET INFECTIOUS DISEASES, 2020, 20 (09): : 1013 - 1014
  • [5] Baricitinib as the treatment of choice for hospitalised individuals with COVID-19
    Richardson, Peter J.
    Stebbing, Justin
    [J]. ECLINICALMEDICINE, 2022, 49
  • [6] Use of baricitinib in treatment of COVID-19: a systematic review
    Sampath, Ananyan
    Banerjee, Aditya
    Atal, Shubham
    Jhaj, Ratinder
    [J]. MEDICINAL RESEARCH REVIEWS, 2023, 43 (05) : 1322 - 1345
  • [7] Baricitinib Is First Approved COVID-19 Immunomodulatory Treatment
    Rubin, Rita
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (23): : 2281 - 2281
  • [8] Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection
    Vitiello, Antonio
    Ferrara, Francesco
    [J]. MOLECULAR BIOLOGY REPORTS, 2022, 49 (01) : 827 - 831
  • [9] Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection
    Antonio Vitiello
    Francesco Ferrara
    [J]. Molecular Biology Reports, 2022, 49 : 827 - 831
  • [10] Longer Steroid Treatment Increases Secondary Bloodstream Infection Risk Among Patients With COVID-19 Requiring Intensive Care
    Dupper, Amy C.
    Malik, Yesha
    Cusumano, Jaclyn A.
    Nadkarni, Devika
    Banga, Jaspreet
    Caban, Ana Berbel
    Twyman, Kathryn
    Obla, Ajay
    Patel, Dhruv
    Mazo, Dana
    Altman, Deena R.
    [J]. INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2022, 30 (04)
12345